|
Related articles:
Celecoxib
Etoricoxib
Eric Topol
Aspirin
Cyclooxygenase
Valdecoxib
Diclofenac
Parecoxib
Clinical trial
Key terms: rofecoxib merck vioxx cardiovascular heart attack fda inhibitors adverse naproxen vigor cardiovascular events nsaids relative risk approve aspirin myocardial warnings plaintiff et al celecoxib placebo litigation nejm increased risk myocardial infarction cardiovascular risk prostaglandins efficacy liable prostacyclin statistically significant cutoff topol vigor study gastrointestinal reuben pmid j med lancet acute pain punitive cutoff date heart disease grassley arrhythmia n engl j med Search external links cited by footnotes on Wikipedia page Rofecoxib: |
|